@FiercePharma: Cost watchdogs veto Novartis breast cancer med Afinitor. NICE says "disappointed" data isn't stronger. News | Follow @FiercePharma
> Indian officials put the brakes on Mylan's ($MYL) plan to buy Strides Arcolab's injectables unit Agila Specialties, deferring approval of the deal for now. Report
> Jordan's Hikma Pharmaceuticals hiked its 2013 forecast, now expecting 17% sales growth thanks to strong sales of a generic antibiotic; its shares rose on the news. Report
> Manufacturers of promotional products--such as logo-bearing pens and sticky notes--are complaining to European officials about the pharma industry's choice to ban them next year. Report
> Novartis ($NVS) joined forces with Biological E, an Indian vaccinemaker, to deliver its typhoid and paratyphoid vaccinations to a set of new countries. Report
> GW Pharmaceuticals said it launched its cannabinoid drug Sativex in Italy. Report
> UCB outlicensed a rheumatoid arthritis drug candidate to Russia's R-Pharm to sell it in Russia and abroad. Report
@FierceMedDev: Roche chases FDA cancer indication for HPV diagnostic. Story | Follow @FierceMedDev
@MarkHFierce: Duke has found early promise with a blood Dx that predicts aspirin treatment success. Report | Follow @MarkHFierce
@DamianFierce: Patient lawsuits mount as India tries to crack down on unethical clinical trials. Item | Follow @DamianFierce
> Alere heads toward proxy fight as activist investor ups ante. Article
> Nikon mulls entry into medical devices business. Story
> Crescendo Bioscience achieves Medicare coverage for RA Dx. News
Biotech News
@FierceBiotech: SEC hunting down traders who made a quick killing on Onyx shares. Report | Follow @FierceBiotech
@JohnCFierce: Top Novartis blockbuster prospect whips Enbrel in psoriasis showdown. News | Follow @JohnCFierce
@RyanMFierce: For those of you who remember Son of Lantus, watch out for Lantus' fraternal (not identical) twin from Lilly and Boehringer. | Follow @RyanMFierce
@EmilyMFierce: Cholera is altering the human genome. Story | Follow @EmilyMFierce
> Swiss biotech OncoEthix snags $19M round to back leukemia drug study. More
> Cytokinetics shares slide on dosing snafu in ALS drug study. Article
> Top Novartis blockbuster prospect whips Enbrel in psoriasis showdown. Story
CRO News
> Report: Academia could better use CROs for early research. News
> Lawsuits mount as India pushes trial reforms. Article
> CRO Blue Sky taps new CEO amid growth. Story
> Parexel teams with Rutgers for clinical trials. More
> CROs shift as early-phase demand dries up. News
Biotech IT News
> Report: Pharma execs warm to med reminder apps. News
> GE, Accenture back analytics provider in $20M financing. Article
> Bioinformatics gives U. Wisconsin team an 'edge' in cystic fibrosis study. Story
> AstraZeneca snaps up drug-discovery software from Cambridge startup. More
> Facebook, Twitter bolster Canadian biotech's research of Crohn's therapy. News
And Finally... New clinics are targeting pregnant women addicted to prescription painkillers to help them quit. Report (sub. req.)